|
1
|
Scagliotti GV, Szczesna A, Ramlau R,
Cardenal F, Mattson K, Van Zandwijk N, Price A, Lebeau B, Debus J
and Manegold C: Docetaxel-based induction therapy prior to
radiotherapy with or without docetaxel for non-small-cell lung
cancer. Br J Cancer. 94:1375–1382. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kocić B, Petrović B, Rancić N and Ilić M:
Lung cancer trends in Southeastern Serbia. Cent Eur J Public
Health. 21:17–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meza R, Meernik C, Jeon J and Cote ML:
Lung cancer incidence trends by gender, race and histology in the
United States, 1973–2010. PLoS One. 10:e01213232015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pathak AK, Bhutani M, Mohan A, Guleria R,
Bal S and Kochupillai V: Non small cell lung cancer (NSCLC):
Current status and future prospects. Indian J Chest Dis Allied Sci.
46:191–203. 2004.PubMed/NCBI
|
|
5
|
Haroun RA, Zakhary NI, Mohamed MR,
Abdelrahman AM, Kandil EI and Shalaby KA: Assessment of the
prognostic value of methylation status and expression levels of
FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian
patients. Asian Pac J Cancer Prev. 15:4281–4287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuo CH, Wu CY, Lee KY, Lin SM, Chung FT,
Lo YL, Liu CY, Hsiung TC, Yang CT and Wu YC: Chronic obstructive
pulmonary disease in stage I non-small cell lung cancer that
underwent anatomic resection: The role of a recurrence promoter.
COPD. 11:407–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumpiro S, Sriuranpong V and Areepium N:
Impact of the copper transporter protein 1 (CTR1) polymorphism on
adverse events among advanced nonsmall cell lung cancer patients
treated with a carboplatin/gemcitabine regimen. Asian Pac J Cancer
Prev. 17:4391–4394. 2016.PubMed/NCBI
|
|
8
|
Merino MJ, Gil S, Macias CG and Lara K:
The unknown microRNA expression of male breast cancer. Similarities
and differences with female ductal carcinoma. Their role as tumor
biomarker. J Cancer. 9:450–459. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: Novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ribas J, Ni X, Castanares M, Liu MM, Esopi
D, Yegnasubramanian S, Rodriguez R, Mendell JT and Lupold SE: A
novel source for miR-21 expression through the alternative
polyadenylation of VMP1 gene transcripts. Nucleic Acids Res.
40:6821–6833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K
and Yang GH: MicroRNA-21 (miR-21) represses tumor suppressor PTEN
and promotes growth and invasion in non-small cell lung cancer
(NSCLC). Clin Chim Acta. 411:846–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang
Y, Zhao J, McCrae MA and Zhuang H: Aberrant expression of microRNA
155 may accelerate cell proliferation by targeting sex-determining
region Y box 6 in hepatocellular carcinoma. Cancer. 118:2431–2442.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao Y, Fu S, Jiang W, Li B, Tian Y and Fu
X: Association of MiR-155 expression with prognosis in resected
stage III non-small cell lung cancer. Zhongguo Fei Ai Za Zhi.
17:417–423. 2014.(In Chinese). PubMed/NCBI
|
|
15
|
Liu F, Song D, Wu Y, Liu X, Zhu J and Tang
Y: MiR-155 inhibits proliferation and invasion by directly
targeting PDCD4 in non-small cell lung cancer. Thorac Cancer.
8:613–619. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gyoba J, Shan S, Roa W and Bédard EL:
Diagnosing lung cancers through examination of micro-RNA biomarkers
in blood, plasma, serum and sputum: A review and summary of current
literature. Int J Mol Sci. 17:4942016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roesel C, Terjung S, Weinreich G, Hager T,
Chalvatzoulis E, Metzenmacher M and Welter S: Sarcomatoid carcinoma
of the lung: A rare histological subtype of non-small cell lung
cancer with a poor prognosis even at earlier tumour stages.
Interact Cardiovasc Thorac Surg. 24:407–413. 2017.PubMed/NCBI
|
|
18
|
Liu J, Shi K, Chen M, Xu L, Hong J, Hu B,
Yang X and Sun R: Elevated miR-155 expression induces
immunosuppression via CD39(+) regulatory T-cells in sepsis patient.
Int J Infect Dis. 40:135–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X,
Shi L, Lu X, Xu W, Lu L, et al: STAT3-regulated exosomal miR-21
promotes angiogenesis and is involved in neoplastic processes of
transformed human bronchial epithelial cells. Cancer Lett.
370:125–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu
K, Wei L and Chu M: The prognostic value of miR-21 and miR-155 in
non-small-cell lung cancer: A meta-analysis. Jpn J Clin Oncol.
43:813–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue X, Liu Y, Wang Y, Meng M, Wang K, Zang
X, Zhao S, Sun X, Cui L, Pan L, et al: MiR-21 and MiR-155 promote
non-small cell lung cancer progression by downregulating SOCS1,
SOCS6, and PTEN. Oncotarget. 7:84508–84519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong
W, Liao Y and Du J: High expression of miR-21 and miR-155 predicts
recurrence and unfavourable survival in non-small cell lung cancer.
Eur J Cancer. 49:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lasithiotaki I, Tsitoura E, Koutsopoulos
A, Lagoudaki E, Koutoulaki C, Pitsidianakis G, Spandidos DA,
Siafakas NM, Sourvinos G and Antoniou KM: Aberrant expression of
miR-21, miR-376c and miR-145 and their target host genes in Merkel
cell polyomavirus-positive non-small cell lung cancer. Oncotarget.
8:112371–112383. 2016.PubMed/NCBI
|
|
24
|
Donnem T, Eklo K, Berg T, Sorbye SW,
Lonvik K, Al-Saad S, Al-Shibli K, Andersen S, Stenvold H, Bremnes
RM, et al: Prognostic impact of MiR-155 in non-small cell lung
cancer evaluated by in situ hybridization. J Transl Med. 9:62011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gironella M, Seux M, Xie MJ, Cano C,
Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, et
al: Tumor protein 53-induced nuclear protein 1 expression is
repressed by miR-155, and its restoration inhibits pancreatic tumor
development. Proc Natl Acad Sci USA. 104:16170–16175. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
